Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
about
Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary deliveryAmpicillin Nanoparticles Production via Supercritical CO2 Gas Antisolvent Process.Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.Pulmonary delivery of anti-inflammatory agents.Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesEntrapment of 5-fluorouracil into PLGA matrices using supercritical antisolvent processes.
P2860
Q34293432-FBE2A3FB-F3D4-4780-A23F-2FA8790F67EBQ34467144-12829A3E-EAF3-4B80-8228-5343AE1EE637Q36442112-1A7C6127-6CF8-4B46-BE85-9A2B4D38DFB0Q38298133-D3886DB1-066A-4722-9CE1-286682341792Q38655920-657A0432-3AC3-42FE-A842-D742B79217AAQ39339379-4F65926C-1C08-4604-AC38-0BB5A3D1CE80Q39576542-7E5CFE2D-D638-41E1-8A32-5809ED0907B2
P2860
Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Experimental study of the GAS ...... itable for pulmonary delivery.
@ast
Experimental study of the GAS ...... itable for pulmonary delivery.
@en
type
label
Experimental study of the GAS ...... itable for pulmonary delivery.
@ast
Experimental study of the GAS ...... itable for pulmonary delivery.
@en
prefLabel
Experimental study of the GAS ...... itable for pulmonary delivery.
@ast
Experimental study of the GAS ...... itable for pulmonary delivery.
@en
P2093
P1476
Experimental study of the GAS ...... itable for pulmonary delivery.
@en
P2093
Paul A Charpentier
Sohrab Rohani
Yousef Bakhbakhi
P356
10.1016/J.IJPHARM.2005.11.008
P407
P577
2006-01-18T00:00:00Z